Top Markets
#1 GEKKO GEKKO +53.94%
#2 Helium Helium +47.23%
#3 Pons Pons +25.55%
#4 Main Street Yield Main Street Yield +17.48%
#5 龙虾 (Lobster) 龙虾 (Lobster) +15.91%
#6 Collect on Fanable Collect on Fanable +14.24%
#7 o1.exchange o1.exchange +14.04%
#8 Ontology Gas Ontology Gas +11.63%
#9 Nockchain Nockchain +11.47%
#10 OpenGradient OpenGradient +10.61%
Coin of the day
GEKKO GEKKO
設定
言語
日本
通貨
USD
テーマ
Inventiva S.A. Inventiva S.A.

Inventiva S.A.

IVA
株式のランク #8990
Inventiva S.A. is a biopharmaceutical firm currently in the clinical... Inventiva S.A. is a biopharmaceutical firm currently in the clinical development phase, specializing in creating orally administered small molecule treatments for conditions such as non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS), and various other ailments. Their primary drug candidate, Lanifibranor, has successfully concluded Phase IIb clinical trials for the management of NASH. Furthermore, the company is advancing Odiparcil, a compound that has finished Phase IIa clinical testing specifically for treating the MPS VI subtype. Beyond these, Inventiva maintains a development pipeline featuring several early-stage projects targeting oncology and other medical conditions. Strategic partnerships are in place with AbbVie to address autoimmune diseases, and with Boehringer Ingelheim International GmbH for innovating therapies for idiopathic pulmonary fibrosis. Established in 2011, Inventiva S.A. operates from its headquarters in Daix, France.
株価
$4.74
最終同期: 2026-08-28
時価総額
$1.12B
変化（1日）
-5.77%
変化（1年）
-16.96%
国
FR
取引 Inventiva S.A. (IVA)

カテゴリー

Healthcare
Inventiva S.A.（IVA）の株価履歴
終値の最高値: $4.81 （2026-08-01）

終値の最安値: $8.81 （2017-02-01）
Inventiva S.A. の株価履歴（2017 ～ 2026）
年間株価パフォーマンス
年 パフォーマンス
2026 (TTM) 16.21%
2025 81.56%
2024 -45.71%
2023 -2.51%
2022 -66.57%
2021 5.74%
2020 247.99%
2019 -44.55%
2018 -2.05%
2017 0.00%
類似企業または競合の株価
企業 株価 変化率 1年% 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $542.09 38.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 44.13%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.53 -12.70%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $138.18 473.58%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $759.27 7.20%
CH